Datasets:
SKT27182
/
NER_processed_data

Dataset card Data Studio Files
xet
Community
1
id
stringlengths
11
11
tags
stringlengths
10
777
text
stringlengths
2
1.5k
dataset_num
int64
1
3
tokens
list
ner_tags
list
NCT02577406
24:38:treatment
Subject has received a targeted agent against an IDH2 mutation
3
[ "Subject", "has", "received", "a", "targeted", "agent", "against", "an", "IDH2", "mutation" ]
[ 0, 0, 0, 0, 1, 1, 0, 0, 0, 0 ]
NCT02451553
16:28:treatment,30:48:treatment,52:74:treatment,
Receipt of any chemotherapy, biological therapy or investigational agents within 3 weeks prior to study registration
3
[ "Receipt", "of", "any", "chemotherapy", ",", "biological", "therapy", "or", "investigational", "agents", "within", "3", "weeks", "prior", "to", "study", "registration" ]
[ 0, 0, 0, 1, 0, 1, 1, 0, 1, 1, 0, 0, 0, 0, 0, 0, 0 ]
NCT03162731
28:50:chronic_disease,84:100:chronic_disease,111:127:treatment,139:150:chronic_disease,154:181:chronic_disease
Patients with uncontrolled intercurrent illnesses including, but not limited to an active infection requiring systemic therapy or a known psychiatric or substance abuse disorder(s) that would interfere with cooperation with the requirements of the trial
3
[ "Patients", "with", "uncontrolled", "intercurrent", "illnesses", "including", ",", "but", "not", "limited", "to", "an", "active", "infection", "requiring", "systemic", "therapy", "or", "a", "known", "psychiatric", "or", "substance", "abuse", "disorder", "(", "s", ")", "that", "would", "interfere", "with", "cooperation", "with", "the", "requirements", "of", "the", "trial" ]
[ 0, 0, 0, 2, 2, 0, 0, 0, 0, 0, 0, 0, 2, 2, 0, 1, 1, 0, 0, 0, 2, 0, 2, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT01773707
1:30:treatment
Insulin autoantibodies (mIAA)
3
[ "Insulin", "autoantibodies", "(", "mIAA", ")" ]
[ 1, 1, 1, 0, 0 ]
NCT02203695
20:23:treatment
Patients must have PSA within study range
3
[ "Patients", "must", "have", "PSA", "within", "study", "range" ]
[ 0, 0, 0, 1, 0, 0, 0 ]
NCT01572480
102:113:treatment,117:129:treatment,160:170:treatment,174:185:treatment,233:243:allergy_name,254:266:allergy_name
History of allergic reactions attributed to compounds of similar chemical or biologic composition to carfilzomib or lenalidomide agents used in study, such as bortezomib or thalidomide, in addition to patients with known allergy to sulfobutyl ether <=- cyclodextrin (Captisol )
3
[ "History", "of", "allergic", "reactions", "attributed", "to", "compounds", "of", "similar", "chemical", "or", "biologic", "composition", "to", "carfilzomib", "or", "lenalidomide", "agents", "used", "in", "study", ",", "such", "as", "bortezomib", "or", "thalidomide", ",", "in", "addition", "to", "patients", "with", "known", "allergy", "to", "sulfobutyl", "ether", "<", "=-", "cyclodextrin", "(", "Captisol", ")" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 4, 0, 0, 0, 4, 0, 0, 0 ]
NCT02573246
47:50:treatment
participants must also be able to tolerate an MRI
3
[ "participants", "must", "also", "be", "able", "to", "tolerate", "an", "MRI" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 1 ]
NCT02911792
,,96:109:treatment
Premenopausal females who are not practicing acceptable contraceptive methods Participation in another trial with an investigational drug
3
[ "Premenopausal", "females", "who", "are", "not", "practicing", "acceptable", "contraceptive", "methods", "Participation", "in", "another", "trial", "with", "an", "investigational", "drug" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 0, 0, 0, 0 ]
NCT03069924
,41:67:treatment
being in the immediate (within 2 weeks) post myocardial infarction period
3
[ "being", "in", "the", "immediate", "(", "within", "2", "weeks", ")", "post", "myocardial", "infarction", "period" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 1, 0 ]
NCT02682407
,51:61:treatment,
For subjects in Cohort 1, have been on ≥ 10 mg of prednisone or equivalent dose for at least 12 weeks prior to Screening
3
[ "For", "subjects", "in", "Cohort", "1", ",", "have", "been", "on", "≥", "10", "mg", "of", "prednisone", "or", "equivalent", "dose", "for", "at", "least", "12", "weeks", "prior", "to", "Screening" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT01419561
1:11:chronic_disease,,
Leukopenia (white cell count<4,000 cells/microL)
3
[ "Leukopenia", "(", "white", "cell", "count", "<", "4,000", "cells/microL", ")" ]
[ 2, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02324387
59:62:treatment
Patients who agree to sign an informed consent to undergo MBI
3
[ "Patients", "who", "agree", "to", "sign", "an", "informed", "consent", "to", "undergo", "MBI" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1 ]
NCT01954173
22:48:chronic_disease
Patients with active inflammatory bowel disease
3
[ "Patients", "with", "active", "inflammatory", "bowel", "disease" ]
[ 0, 0, 0, 2, 2, 2 ]
NCT02131467
1:10:chronic_disease
cirrhosis
3
[ "cirrhosis" ]
[ 2 ]
NCT00670358
,,,84:91:treatment,95:106:treatment,108:121:treatment
Measurable disease, defined as ≥ 1 lesion ≥ 1.5 cm in one diameter, as detected by CT scan or PET-CT scan (PET/CT fusion)
3
[ "Measurable", "disease", ",", "defined", "as", "≥", "1", "lesion", "≥", "1.5", "cm", "in", "one", "diameter", ",", "as", "detected", "by", "CT", "scan", "or", "PET-CT", "scan", "(", "PET/CT", "fusion", ")" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 0, 1, 1, 0, 1, 1, 0 ]
NCT02466009
,,171:181:treatment
Subjects of childbearing potential must agree to use adequate contraception beginning at the signing informed consent form until at least 3 months after the last dose of study drug
3
[ "Subjects", "of", "childbearing", "potential", "must", "agree", "to", "use", "adequate", "contraception", "beginning", "at", "the", "signing", "informed", "consent", "form", "until", "at", "least", "3", "months", "after", "the", "last", "dose", "of", "study", "drug" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1 ]
NCT00975520
1:7:cancer
Tumour located above the clavicle and below the jaw or occiput (neck primary) or above the jaw/occiput (head primary)
3
[ "Tumour", "located", "above", "the", "clavicle", "and", "below", "the", "jaw", "or", "occiput", "(", "neck", "primary", ")", "or", "above", "the", "jaw/occiput", "(", "head", "primary", ")" ]
[ 3, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02178709
7:19:cancer,
Other malignancies within the past 3 years
3
[ "Other", "malignancies", "within", "the", "past", "3", "years" ]
[ 0, 3, 0, 0, 0, 0, 0 ]
NCT02192359
102:112:allergy_name
History of allergic reactions attributed to compounds of similar chemical or biologic composition to irinotecan
3
[ "History", "of", "allergic", "reactions", "attributed", "to", "compounds", "of", "similar", "chemical", "or", "biologic", "composition", "to", "irinotecan" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 4 ]
NCT01554371
96:130:cancer
Patients must have histologically or cytologically confirmed locally advanced, unresectable or metastatic carcinoma of the breast
3
[ "Patients", "must", "have", "histologically", "or", "cytologically", "confirmed", "locally", "advanced", ",", "unresectable", "or", "metastatic", "carcinoma", "of", "the", "breast" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 3, 3, 3, 3, 3 ]
NCT02384954
,,20:23:chronic_disease
No NYHA Class > II CHF
3
[ "No", "NYHA", "Class", ">", "II", "CHF" ]
[ 0, 0, 0, 0, 0, 2 ]
NCT02741180
25:41:chronic_disease,
Patients diagnosed with heart arrhythmia scheduled for routine clinical MRI examinations)
3
[ "Patients", "diagnosed", "with", "heart", "arrhythmia", "scheduled", "for", "routine", "clinical", "MRI", "examinations", ")" ]
[ 0, 0, 0, 2, 2, 0, 0, 0, 0, 0, 0, 0 ]
NCT02429934
,30:40:treatment
Patients requiring >20 mg of prednisone daily
3
[ "Patients", "requiring", ">", "20", "mg", "of", "prednisone", "daily" ]
[ 0, 0, 0, 0, 0, 0, 1, 0 ]
NCT02100956
9:33:treatment
chronic intrathecal drug therapy
3
[ "chronic", "intrathecal", "drug", "therapy" ]
[ 0, 1, 1, 1 ]
NCT02562755
28:50:chronic_disease,74:95:chronic_disease,97:120:chronic_disease
Current or past history of cardiovascular disease (e.g.. past history of myocardial infarction, ischemic cardiomyopathy)
3
[ "Current", "or", "past", "history", "of", "cardiovascular", "disease", "(", "e.g", "..", "past", "history", "of", "myocardial", "infarction", ",", "ischemic", "cardiomyopathy", ")" ]
[ 0, 0, 0, 0, 0, 2, 2, 0, 0, 0, 0, 0, 0, 2, 2, 0, 2, 2, 0 ]
NCT01896999
,62:81:treatment
must not have relapsed within 6 months of receiving previous brentuximab vedotin
3
[ "must", "not", "have", "relapsed", "within", "6", "months", "of", "receiving", "previous", "brentuximab", "vedotin" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1 ]
NCT02159027
14:23:chronic_disease
Diagnosis of cirrhosis
3
[ "Diagnosis", "of", "cirrhosis" ]
[ 0, 0, 2 ]
NCT01333046
10:16:chronic_disease
Unstable angina
3
[ "Unstable", "angina" ]
[ 0, 2 ]
NCT02496208
1:11:cancer,12:22:cancer,23:32:cancer
Clear cell renal cell carcinoma
3
[ "Clear", "cell", "renal", "cell", "carcinoma" ]
[ 3, 3, 3, 3, 3 ]
NCT02061293
1:21:chronic_disease,,
Cognitive impairment (Folstein Mini Mental State Exam score < 26)
3
[ "Cognitive", "impairment", "(", "Folstein", "Mini", "Mental", "State", "Exam", "score", "<", "26", ")" ]
[ 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02576444
15:39:cancer
Patients with primary CNS malignancies
3
[ "Patients", "with", "primary", "CNS", "malignancies" ]
[ 0, 0, 3, 3, 3 ]
NCT02482376
,138:142:cancer
Estrogen receptor positive (ER+), Human epidermal growth factor 2 negative (HER2-) HER-2 status is not required for women diagnosed with DCIS
3
[ "Estrogen", "receptor", "positive", "(", "ER+", ")", ",", "Human", "epidermal", "growth", "factor", "2", "negative", "(", "HER2-", ")", "HER-2", "status", "is", "not", "required", "for", "women", "diagnosed", "with", "DCIS" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 3 ]
NCT02516813
13:45:chronic_disease,70:87:chronic_disease,109:141:chronic_disease,,
Significant cardiac conduction abnormalities, including a history of long QTc syndrome and/or pacemaker, or impaired cardiovascular function such as New York Heart Association classification score >2
3
[ "Significant", "cardiac", "conduction", "abnormalities", ",", "including", "a", "history", "of", "long", "QTc", "syndrome", "and/or", "pacemaker", ",", "or", "impaired", "cardiovascular", "function", "such", "as", "New", "York", "Heart", "Association", "classification", "score", ">", "2" ]
[ 0, 2, 2, 2, 0, 0, 0, 0, 0, 2, 2, 2, 0, 0, 0, 0, 2, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02595996
52:63:allergy_name
Patients with known contraindications to receiving propranolol
3
[ "Patients", "with", "known", "contraindications", "to", "receiving", "propranolol" ]
[ 0, 0, 0, 0, 0, 0, 4 ]
NCT01880567
17:20:cancer,31:58:treatment,64:72:treatment,87:107:treatment
Newly diagnosed MCL: Requires concomitant anticoagulation with warfarin or equivalent vitamin K antagonist
3
[ "Newly", "diagnosed", "MCL", ":", "Requires", "concomitant", "anticoagulation", "with", "warfarin", "or", "equivalent", "vitamin", "K", "antagonist" ]
[ 0, 0, 3, 0, 0, 1, 1, 0, 1, 0, 0, 1, 1, 1 ]
NCT02336451
91:106:treatment
Patients may or may not have neurological symptoms but must be able to swallow and retain oral medication
3
[ "Patients", "may", "or", "may", "not", "have", "neurological", "symptoms", "but", "must", "be", "able", "to", "swallow", "and", "retain", "oral", "medication" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1 ]
NCT03024320
1:21:chronic_disease
Cognitive impairment that may preclude self-directed daily activities
3
[ "Cognitive", "impairment", "that", "may", "preclude", "self-directed", "daily", "activities" ]
[ 2, 2, 0, 0, 0, 0, 0, 0 ]
NCT01990209
31:46:treatment
Ability to swallow and retain oral medication
3
[ "Ability", "to", "swallow", "and", "retain", "oral", "medication" ]
[ 0, 0, 0, 0, 0, 1, 1 ]
NCT02394535
17:27:treatment,31:40:treatment,,98:110:treatment
Patients taking sorivudine or brivudine must be off of these drugs for 4 weeks prior to starting capecitabine
3
[ "Patients", "taking", "sorivudine", "or", "brivudine", "must", "be", "off", "of", "these", "drugs", "for", "4", "weeks", "prior", "to", "starting", "capecitabine" ]
[ 0, 0, 1, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1 ]
NCT02728050
8:23:chronic_disease,87:96:treatment,226:249:chronic_disease,251:285:chronic_disease
Active systemic fungal, bacterial, viral, or other infection, unless disease is under treatment with anti-microbials and/or controlled or stable (e.g. if specific, effective therapy is not available/feasible or desired [e.g. chronic viral hepatitis, human immunodeficiency virus (HIV)])
3
[ "Active", "systemic", "fungal", ",", "bacterial", ",", "viral", ",", "or", "other", "infection", ",", "unless", "disease", "is", "under", "treatment", "with", "anti-microbials", "and/or", "controlled", "or", "stable", "(", "e.g", ".", "if", "specific", ",", "effective", "therapy", "is", "not", "available/feasible", "or", "desired", "[", "e.g", ".", "chronic", "viral", "hepatitis", ",", "human", "immunodeficiency", "virus", "(", "HIV", ")", "]", ")" ]
[ 0, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 2, 2, 2, 0, 2, 2, 2, 2, 0, 0, 0, 0 ]
NCT02515110
38:66:cancer
Histologic documentation of invasive adenocarcinoma of the breast
3
[ "Histologic", "documentation", "of", "invasive", "adenocarcinoma", "of", "the", "breast" ]
[ 0, 0, 0, 0, 3, 3, 3, 3 ]
NCT02415556
65:72:treatment,,105:124:chronic_disease,126:138:cancer,140:161:chronic_disease,162:168:chronic_disease
Acute medical condition that required either hospitalization or surgery within the past 6 months (e.g., severe hypoglycemia, malignancies, myocardial infarction,stroke)
3
[ "Acute", "medical", "condition", "that", "required", "either", "hospitalization", "or", "surgery", "within", "the", "past", "6", "months", "(", "e.g.", ",", "severe", "hypoglycemia", ",", "malignancies", ",", "myocardial", "infarction", ",", "stroke", ")" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 2, 2, 0, 3, 0, 2, 2, 0, 2, 0 ]
NCT02311361
,31:59:cancer
Patients must have at least 1 measurable metastatic lesion by RECIST1.1 criteria
3
[ "Patients", "must", "have", "at", "least", "1", "measurable", "metastatic", "lesion", "by", "RECIST1.1", "criteria" ]
[ 0, 0, 0, 0, 0, 0, 3, 3, 3, 0, 0, 0 ]
NCT02057133
23:109:treatment
Part G: Have received prior therapy with fulvestrant or any PI3K and/or mTOR inhibitor (including LY3023414)
3
[ "Part", "G", ":", "Have", "received", "prior", "therapy", "with", "fulvestrant", "or", "any", "PI3K", "and/or", "mTOR", "inhibitor", "(", "including", "LY3023414", ")" ]
[ 0, 0, 0, 0, 0, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 0, 0 ]
NCT02468024
1:16:treatment
mediastinoscopy
3
[ "mediastinoscopy" ]
[ 1 ]
NCT02053909
1:29:chronic_disease
Active pathological bleeding
3
[ "Active", "pathological", "bleeding" ]
[ 2, 2, 2 ]
NCT02498535
11:31:treatment,
Use of an investigational drug within 30 days prior to screening
3
[ "Use", "of", "an", "investigational", "drug", "within", "30", "days", "prior", "to", "screening" ]
[ 0, 0, 0, 1, 1, 0, 0, 0, 0, 0, 0 ]
NCT01928576
23:33:treatment,35:46:treatment,51:60:treatment,64:83:treatment,76:83:treatment,85:140:treatment
Subjects who received pemetrexed, bevacizumab, or erlotinib as maintenance therapy (nonprogressors with platinum-based doublet chemotherapy) and subsequently progressed after maintenance therapy) are eligible and do not count as a line of therapy
3
[ "Subjects", "who", "received", "pemetrexed", ",", "bevacizumab", ",", "or", "erlotinib", "as", "maintenance", "therapy", "(", "nonprogressors", "with", "platinum-based", "doublet", "chemotherapy", ")", "and", "subsequently", "progressed", "after", "maintenance", "therapy", ")", "are", "eligible", "and", "do", "not", "count", "as", "a", "line", "of", "therapy" ]
[ 0, 0, 0, 1, 0, 1, 0, 0, 1, 0, 1, 1, 0, 1, 1, 1, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02923921
16:34:treatment,
have completed prior chemotherapy at least 2 weeks (washout period) prior to randomization and recovered from toxicity to Grade 1 or baseline
3
[ "have", "completed", "prior", "chemotherapy", "at", "least", "2", "weeks", "(", "washout", "period", ")", "prior", "to", "randomization", "and", "recovered", "from", "toxicity", "to", "Grade", "1", "or", "baseline" ]
[ 0, 0, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02409316
12:36:cancer
History of HER2/neu positive cancer (IHC 3+ and/or FISH positive) as assessed by medical record review at screening
3
[ "History", "of", "HER2/neu", "positive", "cancer", "(", "IHC", "3+", "and/or", "FISH", "positive", ")", "as", "assessed", "by", "medical", "record", "review", "at", "screening" ]
[ 0, 0, 3, 3, 3, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT01200940
16:59:treatment
Current use of prescription or non-prescription medication
3
[ "Current", "use", "of", "prescription", "or", "non-prescription", "medication" ]
[ 0, 0, 0, 1, 1, 1, 1 ]
NCT00975520
19:25:cancer
Occasionally, the tumour itself may form neuroid structures (termed 'neural transformation'; this is also regarded as neurotropism)
3
[ "Occasionally", ",", "the", "tumour", "itself", "may", "form", "neuroid", "structures", "(", "termed", "'neural", "transformation", "'", ";", "this", "is", "also", "regarded", "as", "neurotropism", ")" ]
[ 0, 0, 0, 3, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02478255
1:20:chronic_disease,
Respiratory illness of a bacterial or viral etiology within 30 days of MRI
3
[ "Respiratory", "illness", "of", "a", "bacterial", "or", "viral", "etiology", "within", "30", "days", "of", "MRI" ]
[ 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02107638
24:58:chronic_disease
having other diagnosed neurological diseases or disorders
3
[ "having", "other", "diagnosed", "neurological", "diseases", "or", "disorders" ]
[ 0, 0, 0, 2, 2, 2, 2 ]
NCT02089607
22:39:chronic_disease
In the setting of an aortic dissection
3
[ "In", "the", "setting", "of", "an", "aortic", "dissection" ]
[ 0, 0, 0, 0, 0, 2, 2 ]
NCT01045148
10:24:treatment
Metallic Hip prosthesis
3
[ "Metallic", "Hip", "prosthesis" ]
[ 0, 1, 1 ]
NCT00044304
30:36:treatment
presence of FIP1L1/PDGFRA by RT-PCR
3
[ "presence", "of", "FIP1L1/PDGFRA", "by", "RT-PCR" ]
[ 0, 0, 0, 0, 1 ]
NCT02595866
18:31:chronic_disease,54:70:cancer,90:112:cancer,136:157:cancer
Extensive active brain disease including symptomatic brain metastases or the presence of leptomeningeal disease, and all patients with infratentorial tumors
3
[ "Extensive", "active", "brain", "disease", "including", "symptomatic", "brain", "metastases", "or", "the", "presence", "of", "leptomeningeal", "disease", ",", "and", "all", "patients", "with", "infratentorial", "tumors" ]
[ 0, 0, 3, 3, 0, 0, 0, 0, 0, 0, 0, 0, 3, 3, 0, 0, 0, 0, 0, 3, 3 ]
NCT02036268
38:46:treatment,183:201:treatment,183:190:treatment,248:257:treatment,261:270:treatment
Subjects who currently do NOT have a urostomy or any other type of urinary diversion and/or are NOT planning to have a urostomy or any other type of urinary diversion as part of the surgery procedures at the time of their surgery for placement of colostomy or ileostomy
3
[ "Subjects", "who", "currently", "do", "NOT", "have", "a", "urostomy", "or", "any", "other", "type", "of", "urinary", "diversion", "and/or", "are", "NOT", "planning", "to", "have", "a", "urostomy", "or", "any", "other", "type", "of", "urinary", "diversion", "as", "part", "of", "the", "surgery", "procedures", "at", "the", "time", "of", "their", "surgery", "for", "placement", "of", "colostomy", "or", "ileostomy" ]
[ 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1 ]
NCT03093272
23:39:cancer
Presence of untreated brain metastasis
3
[ "Presence", "of", "untreated", "brain", "metastasis" ]
[ 0, 0, 0, 3, 3 ]
NCT01903330
1:7:chronic_disease,9:34:chronic_disease,36:51:chronic_disease,53:74:chronic_disease,78:102:chronic_disease,,,
Stroke, transient ischemic attack, unstable angina, myocardial infarction or congestive heart failure (New York Heart Association Grade II or greater) within the past 12 months
3
[ "Stroke", ",", "transient", "ischemic", "attack", ",", "unstable", "angina", ",", "myocardial", "infarction", "or", "congestive", "heart", "failure", "(", "New", "York", "Heart", "Association", "Grade", "II", "or", "greater", ")", "within", "the", "past", "12", "months" ]
[ 2, 0, 2, 2, 2, 0, 2, 2, 0, 2, 2, 0, 2, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT03041441
,24:48:chronic_disease
cranial MRI changes of intracranial hypotension
3
[ "cranial", "MRI", "changes", "of", "intracranial", "hypotension" ]
[ 0, 0, 0, 0, 2, 2 ]
NCT02819141
1:12:treatment,34:48:treatment,37:48:treatment,81:92:treatment,,115:128:treatment,,144:152:treatment,
vasopressor dose was higher than norepinephrine or epinephrine 0.15 mcg/kg/min, vasopressin > 2.4 units per hour, phenylephrine >3 mcg/kg/min, dopamine >10 mcg/kg/min or dobutamine at any dose in the prior 6 hours
3
[ "vasopressor", "dose", "was", "higher", "than", "norepinephrine", "or", "epinephrine", "0.15", "mcg/kg/min", ",", "vasopressin", ">", "2.4", "units", "per", "hour", ",", "phenylephrine", ">", "3", "mcg/kg/min", ",", "dopamine", ">", "10", "mcg/kg/min", "or", "dobutamine", "at", "any", "dose", "in", "the", "prior", "6", "hours" ]
[ 1, 0, 0, 0, 0, 1, 0, 1, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT01464034
1:14:treatment,
Major surgery within 21 days prior to first dose
3
[ "Major", "surgery", "within", "21", "days", "prior", "to", "first", "dose" ]
[ 1, 1, 0, 0, 0, 0, 0, 0, 0 ]
NCT02323581
37:59:treatment,63:73:treatment,,91:100:treatment
Participation in another in another investigational device or drug study within 1 year of treatment
3
[ "Participation", "in", "another", "in", "another", "investigational", "device", "or", "drug", "study", "within", "1", "year", "of", "treatment" ]
[ 0, 0, 0, 0, 0, 1, 1, 0, 1, 1, 0, 0, 0, 0, 1 ]
NCT02128802
1:17:chronic_disease
Bipolar disorder
3
[ "Bipolar", "disorder" ]
[ 2, 2 ]
NCT02095678
51:54:treatment
No contraindications to getting contrast enhanced MRI examinations
3
[ "No", "contraindications", "to", "getting", "contrast", "enhanced", "MRI", "examinations" ]
[ 0, 0, 0, 0, 0, 0, 1, 0 ]
NCT02359825
18:39:chronic_disease
diagnosed with a neuromuscular disease
3
[ "diagnosed", "with", "a", "neuromuscular", "disease" ]
[ 0, 0, 0, 2, 2 ]
NCT01639508
1:14:treatment,20:31:treatment,33:70:treatment,,137:150:treatment,,207:220:treatment,226:241:treatment,243:259:treatment,,360:373:treatment
Major surgery (eg, thoracotomy, removal or biopsy of brain metastasis) within 3 months before Week 1 Day 1. Complete wound healing from major surgery must have occurred 1 month before Week 1 Day 1 and from minor surgery (eg, simple excision, tooth extraction) at least 10 days before Week 1 Day 1. Subjects with clinically relevant ongoing complications from prior surgery are not eligible
3
[ "Major", "surgery", "(", "eg", ",", "thoracotomy", ",", "removal", "or", "biopsy", "of", "brain", "metastasis", ")", "within", "3", "months", "before", "Week", "1", "Day", "1", ".", "Complete", "wound", "healing", "from", "major", "surgery", "must", "have", "occurred", "1", "month", "before", "Week", "1", "Day", "1", "and", "from", "minor", "surgery", "(", "eg", ",", "simple", "excision", ",", "tooth", "extraction", ")", "at", "least", "10", "days", "before", "Week", "1", "Day", "1", ".", "Subjects", "with", "clinically", "relevant", "ongoing", "complications", "from", "prior", "surgery", "are", "not", "eligible" ]
[ 1, 1, 0, 0, 0, 1, 0, 1, 1, 1, 1, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 0, 0, 0, 1, 1, 0, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 0, 0, 0 ]
NCT02741791
12:43:treatment,45:68:treatment,70:103:treatment,112:157:treatment,
History of electroconvulsive therapy (ECT), vagus nerve stimulation, transcranial magnetic stimulation, or any experimental central nervous system treatment during the current episode or in the past 6 months
3
[ "History", "of", "electroconvulsive", "therapy", "(", "ECT", ")", ",", "vagus", "nerve", "stimulation", ",", "transcranial", "magnetic", "stimulation", ",", "or", "any", "experimental", "central", "nervous", "system", "treatment", "during", "the", "current", "episode", "or", "in", "the", "past", "6", "months" ]
[ 0, 0, 1, 1, 1, 0, 0, 0, 1, 1, 1, 0, 1, 1, 1, 0, 0, 0, 1, 1, 1, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02474667
36:76:treatment
Recipient of a kidney preserved by normothermic pulsatile machine perfusion
3
[ "Recipient", "of", "a", "kidney", "preserved", "by", "normothermic", "pulsatile", "machine", "perfusion" ]
[ 0, 0, 0, 0, 0, 0, 1, 1, 1, 1 ]
NCT02319369
23:44:treatment
Is willing to undergo malignancy genotyping for TP53 mutation, insertion, or deletion at screening
3
[ "Is", "willing", "to", "undergo", "malignancy", "genotyping", "for", "TP53", "mutation", ",", "insertion", ",", "or", "deletion", "at", "screening" ]
[ 0, 0, 0, 0, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02057133
13:22:treatment,25:36:treatment,58:82:treatment,123:155:treatment,160:178:chronic_disease
For Part B (LY2835219 + anastrozole): Except for ongoing therapy with anastrozole, the participant must not have received prior systemic endocrine therapy for metastatic disease
3
[ "For", "Part", "B", "(", "LY2835219", "+", "anastrozole", ")", ":", "Except", "for", "ongoing", "therapy", "with", "anastrozole", ",", "the", "participant", "must", "not", "have", "received", "prior", "systemic", "endocrine", "therapy", "for", "metastatic", "disease" ]
[ 0, 0, 0, 0, 1, 0, 1, 0, 0, 0, 0, 0, 1, 1, 1, 0, 0, 0, 0, 0, 0, 0, 1, 1, 1, 1, 0, 2, 2 ]
NCT02138669
1:35:chronic_disease
recurrent corneal erosion syndrome
3
[ "recurrent", "corneal", "erosion", "syndrome" ]
[ 2, 2, 2, 2 ]
NCT02710396
14:27:treatment,36:45:treatment,47:57:treatment,59:69:treatment,71:81:treatment,86:152:treatment,164:174:treatment
Has received prior therapy with an anti-PD-1, anti-PD-L1, anti-PD-L2, anti-CD137, or anti-Cytotoxic T-lymphocyte-associated antigen-4 (CTLA-4) antibody (including ipilimumab or any other antibody or drug specifically targeting T-cell co-stimulation or checkpoint pathways)
3
[ "Has", "received", "prior", "therapy", "with", "an", "anti-PD-1", ",", "anti-PD-L1", ",", "anti-PD-L2", ",", "anti-CD137", ",", "or", "anti-Cytotoxic", "T-lymphocyte-associated", "antigen-4", "(", "CTLA-4", ")", "antibody", "(", "including", "ipilimumab", "or", "any", "other", "antibody", "or", "drug", "specifically", "targeting", "T-cell", "co-stimulation", "or", "checkpoint", "pathways", ")" ]
[ 0, 0, 1, 1, 0, 0, 1, 0, 1, 0, 1, 0, 1, 0, 0, 1, 1, 1, 1, 1, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02048332
13:16:treatment,20:31:treatment,,50:62:treatment
Infusion of ATG or alemtuzumab within 2 weeks of CTL infusion
3
[ "Infusion", "of", "ATG", "or", "alemtuzumab", "within", "2", "weeks", "of", "CTL", "infusion" ]
[ 0, 0, 1, 0, 1, 0, 0, 0, 0, 1, 1 ]
NCT02964741
16:39:treatment
Current use of opioid pain medications
3
[ "Current", "use", "of", "opioid", "pain", "medications" ]
[ 0, 0, 0, 1, 1, 1 ]
NCT01379573
41:44:treatment,41:45:treatment,,,714:731:chronic_disease,,,,,
Mother may or may not already be taking HCQ. This latter point was discussed with Dr. Nathalie Costedoat-Chalumeau, who has published extensively on measurement of HCQ. While it might be optimal for the mothers anticipating enrollment in the study to all have been on HCQ prior to conception, this is impractical. Some may never achieve pregnancy and not want to take HCQ unless they conceive (especially those asymptomatic). On the other hand, women with SLE are likely to already be on HCQ and it would limit enrollment to exclude these patients if all must initiate HCQ only at enrollment in the first trimester. Although the accepted dogma is that HCQ requires several months for maximal efficacy in treating rheumatic disease, it is unknown whether this would apply to transplacental passage or fetal levels (which are impossible to measure). Dr. Costedoat-Chalumeau suggests that HCQ is probably a three compartment model which includes the circulation, tissues and cells. In the circulation, the half life is approximately 7 days and in the tissues, it is 40 days. In Dr. Costedoat-Chalumeau's experience, steady state blood levels of HCQ are achieved in 4-6 weeks. Thus, dosing the mother no later than 10 weeks gestation should provide sufficient fetal exposure before the vulnerable period of CHB which is generally accepted to span 18-24 wks. Furthermore, the placenta has to be formed for HCQ to gain access to the fetus and it may be effective quickly for the biology we are considering
3
[ "Mother", "may", "or", "may", "not", "already", "be", "taking", "HCQ", ".", "This", "latter", "point", "was", "discussed", "with", "Dr.", "Nathalie", "Costedoat-Chalumeau", ",", "who", "has", "published", "extensively", "on", "measurement", "of", "HCQ", ".", "While", "it", "might", "be", "optimal", "for", "the", "mothers", "anticipating", "enrollment", "in", "the", "study", "to", "all", "have", "been", "on", "HCQ", "prior", "to", "conception", ",", "this", "is", "impractical", ".", "Some", "may", "never", "achieve", "pregnancy", "and", "not", "want", "to", "take", "HCQ", "unless", "they", "conceive", "(", "especially", "those", "asymptomatic", ")", ".", "On", "the", "other", "hand", ",", "women", "with", "SLE", "are", "likely", "to", "already", "be", "on", "HCQ", "and", "it", "would", "limit", "enrollment", "to", "exclude", "these", "patients", "if", "all", "must", "initiate", "HCQ", "only", "at", "enrollment", "in", "the", "first", "trimester", ".", "Although", "the", "accepted", "dogma", "is", "that", "HCQ", "requires", "several", "months", "for", "maximal", "efficacy", "in", "treating", "rheumatic", "disease", ",", "it", "is", "unknown", "whether", "this", "would", "apply", "to", "transplacental", "passage", "or", "fetal", "levels", "(", "which", "are", "impossible", "to", "measure", ")", ".", "Dr.", "Costedoat-Chalumeau", "suggests", "that", "HCQ", "is", "probably", "a", "three", "compartment", "model", "which", "includes", "the", "circulation", ",", "tissues", "and", "cells", ".", "In", "the", "circulation", ",", "the", "half", "life", "is", "approximately", "7", "days", "and", "in", "the", "tissues", ",", "it", "is", "40", "days", ".", "In", "Dr.", "Costedoat-Chalumeau", "'s", "experience", ",", "steady", "state", "blood", "levels", "of", "HCQ", "are", "achieved", "in", "4-6", "weeks", ".", "Thus", ",", "dosing", "the", "mother", "no", "later", "than", "10", "weeks", "gestation", "should", "provide", "sufficient", "fetal", "exposure", "before", "the", "vulnerable", "period", "of", "CHB", "which", "is", "generally", "accepted", "to", "span", "18-24", "wks", ".", "Furthermore", ",", "the", "placenta", "has", "to", "be", "formed", "for", "HCQ", "to", "gain", "access", "to", "the", "fetus", "and", "it", "may", "be", "effective", "quickly", "for", "the", "biology", "we", "are", "considering" ]
[ 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1 ]
NCT01989585
1:14:treatment,114:133:treatment,145:159:treatment,161:171:treatment,173:182:treatment,194:218:treatment,223:235:treatment,245:261:treatment,263:277:treatment,285:306:treatment
Prior therapy is allowed; for patients enrolled in the Phase II portion of the study, patients may have received prior immunotherapy (including high-dose IL-2, ipilimumab, nivolumab, and other anti-PD1/PDL1 antibodies) or chemotherapy; however prior navitoclax, BRAF inhibitor and/or MEK inhibitor therapy will not be allowed
3
[ "Prior", "therapy", "is", "allowed", ";", "for", "patients", "enrolled", "in", "the", "Phase", "II", "portion", "of", "the", "study", ",", "patients", "may", "have", "received", "prior", "immunotherapy", "(", "including", "high-dose", "IL-2", ",", "ipilimumab", ",", "nivolumab", ",", "and", "other", "anti-PD1/PDL1", "antibodies", ")", "or", "chemotherapy", ";", "however", "prior", "navitoclax", ",", "BRAF", "inhibitor", "and/or", "MEK", "inhibitor", "therapy", "will", "not", "be", "allowed" ]
[ 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 0, 0, 1, 1, 0, 1, 0, 1, 0, 0, 0, 1, 1, 0, 0, 1, 0, 0, 0, 0, 0, 1, 1, 0, 1, 1, 1, 0, 0, 0, 0 ]
NCT02498613
12:33:chronic_disease,,
History of myocardial infarction within 12 months (patients with history of myocardial infarction within 6 months are excluded from the study)
3
[ "History", "of", "myocardial", "infarction", "within", "12", "months", "(", "patients", "with", "history", "of", "myocardial", "infarction", "within", "6", "months", "are", "excluded", "from", "the", "study", ")" ]
[ 0, 0, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT03180905
32:42:chronic_disease
Currently not suffering from a concussion or being treated for a concussion, unless enrolled in the subgroup Discriminative Validit
3
[ "Currently", "not", "suffering", "from", "a", "concussion", "or", "being", "treated", "for", "a", "concussion", ",", "unless", "enrolled", "in", "the", "subgroup", "Discriminative", "Validit" ]
[ 0, 0, 0, 0, 0, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02373644
,25:47:treatment,65:92:treatment,96:143:treatment
A minimum of 3 positive pain provocation tests using either the Laslett et al. (2003, 2005) or van der Wurff et al (2006) multi-test regiments
3
[ "A", "minimum", "of", "3", "positive", "pain", "provocation", "tests", "using", "either", "the", "Laslett", "et", "al", ".", "(", "2003", ",", "2005", ")", "or", "van", "der", "Wurff", "et", "al", "(", "2006", ")", "multi-test", "regiments" ]
[ 0, 0, 0, 0, 0, 1, 1, 1, 0, 0, 0, 1, 1, 1, 1, 1, 0, 0, 0, 0, 0, 1, 1, 1, 1, 1, 1, 1, 1, 0, 0 ]
NCT02389517
1:22:chronic_disease
Uncontrolled diabetes
3
[ "Uncontrolled", "diabetes" ]
[ 2, 2 ]
NCT02305537
1:15:chronic_disease
Panic Disorder
3
[ "Panic", "Disorder" ]
[ 2, 2 ]
NCT02719964
1:41:chronic_disease
Attention Deficit Hyperactivity Disorder
3
[ "Attention", "Deficit", "Hyperactivity", "Disorder" ]
[ 2, 2, 2, 2 ]
NCT01994382
1:14:treatment,
Major surgery within 4 weeks
3
[ "Major", "surgery", "within", "4", "weeks" ]
[ 1, 1, 0, 0, 0 ]
NCT02411773
1:50:treatment
Treatment with central alpha agonists (clonidine)
3
[ "Treatment", "with", "central", "alpha", "agonists", "(", "clonidine", ")" ]
[ 1, 1, 1, 1, 1, 1, 0, 0 ]
NCT00001379
1:8:chronic_disease
hepatic
3
[ "hepatic" ]
[ 2 ]
NCT02914483
1:15:chronic_disease
cardiac trauma
3
[ "cardiac", "trauma" ]
[ 2, 2 ]
NCT02530463
,,,,182:191:treatment,,,316:325:treatment,377:398:treatment
Females of childbearing potential must have a negative serum or urine beta human chorionic gonadotrophin (beta-hCG) pregnancy test result within 24 hours prior to the first dose of treatment and must agree to use an effective contraception method to avoid pregnancy for 23 weeks (30 days plus the time required for nivolumab to undergo five half-lives) after the last dose of investigational drugs
3
[ "Females", "of", "childbearing", "potential", "must", "have", "a", "negative", "serum", "or", "urine", "beta", "human", "chorionic", "gonadotrophin", "(", "beta-hCG", ")", "pregnancy", "test", "result", "within", "24", "hours", "prior", "to", "the", "first", "dose", "of", "treatment", "and", "must", "agree", "to", "use", "an", "effective", "contraception", "method", "to", "avoid", "pregnancy", "for", "23", "weeks", "(", "30", "days", "plus", "the", "time", "required", "for", "nivolumab", "to", "undergo", "five", "half-lives", ")", "after", "the", "last", "dose", "of", "investigational", "drugs" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1 ]
NCT02314377
,,44:54:treatment
Age greater than 18 years at time of first study drug administration
3
[ "Age", "greater", "than", "18", "years", "at", "time", "of", "first", "study", "drug", "administration" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 0 ]
NCT02885649
12:19:chronic_disease,81:96:chronic_disease,112:124:chronic_disease
History of seizure or any condition that may predispose to seizure (e.g., prior cortical stroke or significant brain trauma)
3
[ "History", "of", "seizure", "or", "any", "condition", "that", "may", "predispose", "to", "seizure", "(", "e.g.", ",", "prior", "cortical", "stroke", "or", "significant", "brain", "trauma", ")" ]
[ 0, 0, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 2, 2, 0, 0, 2, 2, 0 ]
NCT03170375
1:10:chronic_disease
cirrhosis
3
[ "cirrhosis" ]
[ 2 ]
NCT02939183
1:17:cancer,
Multiple myeloma with IgM subtype
3
[ "Multiple", "myeloma", "with", "IgM", "subtype" ]
[ 3, 3, 0, 0, 0 ]
NCT02143830
1:21:treatment
red cell transfusion dependence
3
[ "red", "cell", "transfusion", "dependence" ]
[ 1, 1, 1, 0 ]
NCT02106650
10:31:treatment,33:42:treatment,47:54:treatment,,85:94:treatment
used any investigational drugs, biologics, or devices within 14 days prior to study treatment or plans to use any of these during the course of the study
3
[ "used", "any", "investigational", "drugs", ",", "biologics", ",", "or", "devices", "within", "14", "days", "prior", "to", "study", "treatment", "or", "plans", "to", "use", "any", "of", "these", "during", "the", "course", "of", "the", "study" ]
[ 0, 0, 1, 1, 0, 1, 0, 0, 1, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02968602
1:35:treatment
Treatment with oral contraceptives (unless a second form of birth control is used and documented)
3
[ "Treatment", "with", "oral", "contraceptives", "(", "unless", "a", "second", "form", "of", "birth", "control", "is", "used", "and", "documented", ")" ]
[ 1, 1, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02384954
42:58:treatment
Must have recovered from side effects of prior treatments
3
[ "Must", "have", "recovered", "from", "side", "effects", "of", "prior", "treatments" ]
[ 0, 0, 0, 0, 0, 0, 0, 1, 1 ]
NCT03113825
11:36:cancer
Recurrent ipsilateral breast cancer
3
[ "Recurrent", "ipsilateral", "breast", "cancer" ]
[ 0, 3, 3, 3 ]
NCT01238120
30:55:chronic_disease,
Have been hospitalized for a major psychiatric illness within the last 5 years
3
[ "Have", "been", "hospitalized", "for", "a", "major", "psychiatric", "illness", "within", "the", "last", "5", "years" ]
[ 0, 0, 0, 0, 0, 2, 2, 2, 0, 0, 0, 0, 0 ]